BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-275@pharmaconomics
DTSTAMP:20260707T010021Z
DTSTART;VALUE=DATE:20260823
DTEND;VALUE=DATE:20260824
SUMMARY:RARE PDUFA — DTX401
DESCRIPTION:The FDA's approval decision on DTX401 for glycogen storage disease type Ia (GSDIa) is due Aug 23\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1515673/000119312526048738/rare-ex99_1.htm\n\nTrack it: https://www.pharmaconomics.com/e/275
URL:https://www.pharmaconomics.com/e/275
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RARE catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR